scholarly journals S0709 IBD Clinic On-Site Vaccination Services and Vaccination Completion Rates in Patients With Inflammatory Bowel Disease

2020 ◽  
Vol 115 (1) ◽  
pp. S356-S356
Author(s):  
Nadeen Hussain ◽  
Deborah Proctor ◽  
Elizabeth Ruggiero ◽  
Badr Al-Bawardy
2019 ◽  
Vol 2 (Supplement_2) ◽  
pp. 235-236
Author(s):  
F Bergeron ◽  
P Rosenfeld ◽  
Y Leung ◽  
B Bressler ◽  
G Rosenfeld

Author(s):  
Freddy Caldera ◽  
Sophie Balzora ◽  
Mary S Hayney ◽  
Francis A Farraye ◽  
Raymond K Cross

Abstract The recent emergency use authorization of a third COVID-19 vaccine means that most patients with inflammatory bowel disease (IBD) will soon be eligible to be vaccinated. Gastroenterology clinicians should be prepared to address patients’ concerns regarding safety and efficacy of vaccines. They should also strongly recommend that all their patients be vaccinated with a COVID-19 vaccine. Additionally, they should be prepared to educate patients about logistics that will result in successful vaccination completion. All these measures will be crucial to ensure high uptake among their patients with IBD.


Sign in / Sign up

Export Citation Format

Share Document